Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
about
Translating genomic profiling to gastrointestinal cancer treatment.Recent advances in preoperative management of esophageal adenocarcinomaGenomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis.Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.The neoepitope landscape in pediatric cancers.Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.Genomic approaches to accelerate cancer interception.ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.Esophageal Cancer: New Insights into a Heterogenous Disease.New agents on the horizon in gastric cancer.Molecular subtypes in cancers of the gastrointestinal tract.The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.Application of a multi-gene next-generation sequencing panel to a non-invasive oesophageal cell-sampling device to diagnose dysplastic Barrett's oesophagus.Depletion of somatic mutations in splicing-associated sequences in cancer genomes.Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance.Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.Personal Cancer Genome Reporter: variant interpretation report for precision oncology.Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.Computational approaches for discovery of mutational signatures in cancer.Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort study.Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.NSAID use and somatic exomic mutations in Barrett's esophagus.Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.In the literature: October 2016.Validating the concept of mutational signatures with isogenic cell models.siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients.Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets.The direction of travel to better outcomes for patients with oesophago-gastric cancer.Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein ActivationOrganoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeuticsWhole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterationsSelection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus
P2860
Q30239109-C095B1B5-2A04-4432-9894-07AE6C1865F1Q33589301-A6FBE6CF-1363-495B-B99D-5E5BC2824EF3Q33600507-F69B203A-8534-4B28-A1CA-66E01DAE30CEQ33769334-4311CAC3-18F0-41E8-A6B1-8D5721521CE0Q38369640-25DFFD7E-F454-475A-9E1F-29710CAF6053Q38599134-A6046878-DD94-46A6-A16F-3027252DAD7EQ38601828-31A77C02-17D2-414D-9FBD-8ECC2CC0C3E0Q38613413-AD6D07A7-F604-4FC0-8026-9772C1B61548Q38651767-59DE2948-52CE-44E6-90F1-A48EAD654D6AQ38704019-092203D9-6009-4ED0-8397-E9028C9C2FF8Q38734003-E8B32CEA-2110-4C0C-B1F0-6F16959EB303Q38759129-8992B035-D3AB-45E5-A243-3BEC61EBA6DFQ39235977-A4C8F17B-74F6-4721-A177-D7310B669E0EQ39440077-CC661FFA-DE19-4850-BD0D-E8B599D772A0Q42131289-05211E66-761D-466C-AE76-140CEBFF45CEQ42361543-59CDE255-232E-4D98-9FC3-487295CF5101Q43728022-EDE5E718-10D4-4D59-B4B6-7E0921559EB4Q46430064-DE8FDDC5-BD06-4927-8856-E6817F5EEDC2Q47142338-730CE9DC-A8C2-40CE-8B4D-A8482D59D442Q47146363-5A21D237-DBE9-47A8-A63F-B223FC9640F3Q47258949-9841D522-E234-47B1-8DE6-9B4756FB8C71Q47584566-F50BCFE2-1539-4DBD-814B-A82FE7FA062EQ47584718-C6C571E7-440B-44AC-A484-777C779E3825Q47664589-C6FCE650-8317-4F79-80E8-78CE39FB4DBFQ48340965-C2501F57-444F-4034-BA45-38F42EB83B61Q49873966-153CDFFE-C4EE-4F93-918F-1350F25464FAQ51746842-B33BD0F1-4C2A-4C66-BD16-648ADF3B5765Q52581750-B531B237-3A97-4C72-B3EE-DCD4D73BD8BEQ52603962-93E8B6FF-743B-4C6E-BE49-7F606A873C0EQ54023284-16F0FB1F-F989-4AD1-9D14-B3016375CF4CQ55283304-E3F25D58-6DAE-46AE-AA5E-F3633DAA9DF7Q55317227-54E40BE8-FBEF-4AC5-89D1-C8D92C6BACDEQ55343122-335D9636-FA6F-4BDB-874E-F0DC6D7220E8Q55374001-85197593-EC84-4C38-AE5E-CD6630B94B36Q55383833-8A05DB8E-9D6F-48B3-A7D6-C23FD6F4E8D0Q55654316-1A16A8D9-1970-4958-86DB-1FB715A5EE0FQ57109201-B92AFB51-784F-4A49-8D27-ACB4CAB1F17BQ57900923-0B9B9487-395B-43C5-9646-A7CDC36A70E4Q58118126-BB7EF9AF-F246-4127-B867-056E19A9F654Q58430333-7DA70AEB-A48E-45B9-9125-69854866646B
P2860
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mutational signatures in esoph ...... ps with therapeutic relevance.
@en
type
label
Mutational signatures in esoph ...... ps with therapeutic relevance.
@en
prefLabel
Mutational signatures in esoph ...... ps with therapeutic relevance.
@en
P2093
P2860
P50
P356
P1433
P1476
Mutational signatures in esoph ...... ups with therapeutic relevance
@en
P2093
Ahmad Miremadi
Andrew P Barbour
Anna Grabowska
Barbara Nutzinger
Hamza Chettouh
Jan Bornschein
Jason Crawte
John Saunders
Lawrence Bower
Maria O'Donovan
P2860
P2888
P304
P356
10.1038/NG.3659
P407
P50
P577
2016-09-05T00:00:00Z